Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report)’s stock price passed below its 50-day moving average during trading on Thursday after Zacks Research downgraded the stock from a hold rating to a strong sell rating. The stock has a 50-day moving average of $68.23 and traded as low as $66.02. Lonza Group shares last traded at $66.36, with a volume of 50,903 shares.
Lonza Group Price Performance
The stock has a 50 day simple moving average of $68.23 and a 200 day simple moving average of $68.67. The company has a quick ratio of 0.87, a current ratio of 1.46 and a debt-to-equity ratio of 0.48.
About Lonza Group
Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.
The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.
Featured Articles
- Five stocks we like better than Lonza Group
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Wall Street’s New Sports Prediction Trade
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
